✦ LIBER ✦

CyberKnife Stereotactic Radiosurgery for Recurrent Squamous Cell Carcinoma of the Head and Neck Following Salvage Surgery with Close or Positive Margins

✍ Scribed by Christian P. Hasney; Robert G. Swanton; Paul L. Friedlander

Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 566 KB
Volume: 120
Category: Article
ISSN: 0023-852X
DOI: 10.1002/lary.21616

No coin nor oath required. For personal study only.

✦ Synopsis

Squamous cell carcinoma of the head and neck (SCCHN) has traditionally been treated with a combination of surgery, chemotherapy, and external beam radiotherapy. While cure is generally the goal of these therapeutic modalities, recurrence is an unfortunately common outcome. Salvage surgery often results in close or positive surgical margins and the patient is at high risk for recurrence. Cyberknife stereotactic radiosurgery is a novel treatment that may benefit this subset of patients. This targeted treatment has shown promise in improving local control rates of tumors at multiple sites; however, the data for recurrent SCCHN is limited. In this case series, we present our experience with Cyberknife therapy in SCCHN patients who have undergone salvage surgery with close or positive margins.

📜 SIMILAR VOLUMES

Paclitaxel, cisplatin, and 5-fluorouraci

Paclitaxel, cisplatin, and 5-fluorouracil for patients with advanced or recurrent squamous cell carcinoma of the head and neck

✍ Maha Hussain; Shirish Gadgeel; Omer Kucuk; Wei Du; Walter Salwen; John Ensley 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 73 KB 👁 3 views

## BACKGROUND. The combination of cisplatin and 5-flurouracil (5-FU) is considered standard therapy for patients with recurrent or metastatic squamous cell carcinoma of the head and neck (SCCHN). Paclitaxel has exhibited single-agent activity in patients with this disease. The authors conducted thi

Postoperative brachytherapy alone and co

Postoperative brachytherapy alone and combined postoperative radiotherapy and brachytherapy boost for squamous cell carcinoma of the oral cavity, with positive or close margins

✍ Michel Lapeyre; Marc A. Bollet; Severine Racadot; Lionnel Geoffrois; Marie-Chris 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB

## Abstract ## Background. Postoperative radiotherapy is necessary for squamous cell carcinoma (SCC) of the oral cavity with positive or close margins. The aim of the study is to define the indications of postoperative brachytherapy (BRT). ## Methods. From 1979 to 1993, 82 patients with positive

Ifosfamide, cisplatin, and 13-Cis retino

Ifosfamide, cisplatin, and 13-Cis retinoic acid for patients with advanced or recurrent squamous cell carcinoma of the head and neck : A Phase I–II study

✍ Francesco Recchia; Angelo Lalli; Marco Lombardo; Sandro De Filippis; Gaetano Sag 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 100 KB 👁 3 views

A randomized phase III study of cisplati

A randomized phase III study of cisplatin with or without methotrexate for recurrent squamous cell carcinoma of the head and neck. A Northern California oncology group study

✍ Charlotte Jacobs; Frederick Meyers; Charles Hendrickson; Marsha Kohler; Steve Ca 📂 Article 📅 1983 🏛 John Wiley and Sons 🌐 English ⚖ 500 KB

Combination of cis-platinum and bleomyci

Combination of cis-platinum and bleomycin prior to surgery and/or radiotherapy compared with radiotherapy alone for the treatment of advanced squamous cell carcinoma of the head and neck

✍ Joseph L. Pennacchio; Waun Ki Hong; Stanley Shapshay; Thomas Gillis; Charles Vau 📂 Article 📅 1982 🏛 John Wiley and Sons 🌐 English ⚖ 621 KB

Forty-one patients with unresectable Stage IV head and neck squamous cell carcinoma were treated with combined modality therapy (CM) consisting of induction chemotherapy followed by surgery and/ or radiotherapy (RT). Treatment and survival results are reported and compared to results obtained in tre